{"id":"https://openalex.org/W2551679971","doi":"https://doi.org/10.1093/ofid/ofw172.1356","title":"WCK 4873 (Nafithromycin): Assessment of In Vitro Human CYP Inhibitory Potential of a Novel Lactone-Ketolide","display_name":"WCK 4873 (Nafithromycin): Assessment of In Vitro Human CYP Inhibitory Potential of a Novel Lactone-Ketolide","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2551679971","doi":"https://doi.org/10.1093/ofid/ofw172.1356","mag":"2551679971"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofw172.1356","doi":"https://doi.org/10.1093/ofid/ofw172.1356","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1356","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/1808/28685792/ofw172.1356.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/1808/28685792/ofw172.1356.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089607480","display_name":"Rajesh P. Chavan","orcid":"https://orcid.org/0000-0001-5611-5251","observed_orcids":["https://orcid.org/0000-0001-5611-5251"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajesh Chavan","raw_affiliation_strings":["Wockhardt Research Center, Aurangabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wockhardt Research Center, Aurangabad, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008510245","display_name":"Vineet Zope","orcid":"https://orcid.org/0000-0002-5980-9416","observed_orcids":["https://orcid.org/0000-0002-5980-9416"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vineet Zope","raw_affiliation_strings":["Wockhardt Research Center, Aurangabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wockhardt Research Center, Aurangabad, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031990327","display_name":"Ravindra D Yeole","orcid":"https://orcid.org/0000-0003-4812-4259","observed_orcids":["https://orcid.org/0000-0003-4812-4259"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ravindra Yeole","raw_affiliation_strings":["Wockhardt Research Center, Aurangabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wockhardt Research Center, Aurangabad, India","institution_ids":["https://openalex.org/I4210102159"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101470071","display_name":"Mahesh V. Patel","orcid":"https://orcid.org/0000-0002-5128-4061","observed_orcids":["https://orcid.org/0000-0002-5128-4061"]},"institutions":[{"id":"https://openalex.org/I4210102159","display_name":"Wockhardt (India)","ror":"https://ror.org/01djxaj77","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210102159"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Mahesh Patel","raw_affiliation_strings":["Wockhardt Research Center, Aurangabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wockhardt Research Center, Aurangabad, India","institution_ids":["https://openalex.org/I4210102159"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210102159"],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":1.2169,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.73330699,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"3","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.7429999709129333},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9350000023841858},{"id":"https://openalex.org/keywords/solithromycin","display_name":"solithromycin","score":0.8600000143051147},{"id":"https://openalex.org/keywords/telithromycin","display_name":"telithromycin","score":1.0},{"id":"https://openalex.org/keywords/cethromycin","display_name":"cethromycin","score":1.0},{"id":"https://openalex.org/keywords/cyp3a4-5","display_name":"CYP3A4/5","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9900000095367432},{"id":"https://openalex.org/keywords/time-dependent-inhibition","display_name":"time-dependent inhibition","score":0.7960000038146973},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":0.7559999823570251},{"id":"https://openalex.org/keywords/testosterone","display_name":"testosterone","score":0.6420000195503235},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2780894585","wikidata":"https://www.wikidata.org/wiki/Q1445686","display_name":"Ketolide","level":4,"score":0.8081328868865967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7400692701339722},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.47423216700553894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45298466086387634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1662667691707611},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.12794706225395203},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.11663287878036499},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10471272468566895},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.07626152038574219}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofw172.1356","doi":"https://doi.org/10.1093/ofid/ofw172.1356","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1356","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/1808/28685792/ofw172.1356.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofw172.1356","doi":"https://doi.org/10.1093/ofid/ofw172.1356","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1356","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/1808/28685792/ofw172.1356.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2551679971.pdf","grobid_xml":"https://content.openalex.org/works/W2551679971.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3093291112","https://openalex.org/W2805534054","https://openalex.org/W1984827171","https://openalex.org/W4313367379","https://openalex.org/W2315093988","https://openalex.org/W4211048538","https://openalex.org/W4296250631","https://openalex.org/W7097889977","https://openalex.org/W2136613655","https://openalex.org/W2078318746"],"abstract_inverted_index":{"Background.":[0],"Macrolide":[1],"and":[2,38,51,60,72,92,109,117,134,140,158,165,179,186,194,204,220,239,245,247,250,262,288,332,341,348,352,359,363],"ketolide":[3],"class":[4],"of":[5,33,77,99,119,128,145,153,226,272,298,316],"community":[6],"antibacterials":[7],"are":[8],"generally":[9],"associated":[10],"with":[11,103,112,148],"CYP":[12,30,41,276],"inhibitory":[13,31,42],"activity":[14,147],"leading":[15],"to":[16,268,305],"undesirable":[17],"drug-drug":[18,318],"interaction":[19,319],"potential.":[20,228],"In":[21],"the":[22,115,255,296,310],"present":[23],"study,":[24],"we":[25],"investigated":[26],"in":[27,114],"vitro":[28],"human":[29,56,275],"potential":[32,43,200,233,290,304,315],"WCK":[34,122,191,214,264,284,299,321],"4873,":[35,192,285],"solithromycin,":[36,177],"telithromycin,":[37,237],"cethromycin.":[39],"Methods.":[40],"for":[44,176,213,236,254,320],"CYP1A2,":[45,129],"CYP2B6,":[46,130],"CYP2C8,":[47,131],"CYP2C9,":[48,132],"CYP2C19,":[49,133],"CYP2D6,":[50],"CYP3A4/5was":[52],"assessed":[53,84],"using":[54,161],"pooled":[55],"liver":[57],"microsomes":[58],"(HLM)":[59],"isoform":[61],"specific":[62],"probe":[63],"substrates":[64,223],"by":[65,79,85],"LC-MS/MS":[66],"method.":[67],"The":[68],"time-dependent":[69],"inhibition":[70,75,127,199],"(TDI)":[71],"metabolism":[73],"dependent":[74,150],"(MDI)":[76],"CYP3A4/5":[78,146,307],"all":[80,273],"test":[81,100],"compounds":[82],"were":[83,106,181],"IC50":[86,151,174,211],"shift":[87,212],"approach":[88],"employing":[89,171,218],"midazolam":[90,162],"(MDZ)":[91],"testosterone":[93,221],"(TST)":[94],"as":[95,167,222],"substrates.":[96],"Multiple":[97],"concentrations":[98],"ketolides":[101],"along":[102],"reference":[104],"inhibitors":[105],"preincubated":[107],"(0":[108],"30":[110],"minutes)":[111],"HLM":[113],"presence":[116],"absence":[118,225],"NADPH.":[120],"Results.":[121],"4873":[123,215,265,300,322],"did":[124],"not":[125,302],"show":[126],"CYP2D6":[135,198],"(IC50":[136,241],">":[137],"300":[138],"\u00b5M)":[139],"was":[141,216,234,266,291],"a":[142,230,270,313],"weak":[143],"inhibitor":[144],"substrate":[149],"values":[152],"83.8":[154],"\u00b5M,":[155,157,183,185,188,206],"70.2":[156],">300":[159],"\u00b5M":[160],"(MDZ),":[163],"nifedipine":[164],"TST":[166],"substrates,":[168,173],"respectively.":[169,189],"Contrastingly,":[170],"these":[172],"range":[175],"telithromycin":[178,195],"cethromycin":[180,238],"1.2\u20136":[182],"19.4\u2013103":[184],"14.9\u201345.7":[187],"Unlike":[190,259],"solithromycin":[193,240],"showed":[196],"significant":[197],"(IC50:":[201],"224,":[202],"95,":[203],"39":[205],"respectively).":[207],"For":[208,283],"CYP3A4/5,":[209],"no":[210,286],"observed":[217,235],"MDZ":[219],"indicating":[224,293],"MDI":[227,232,289],"However,":[229],"higher":[231,281],"shift:":[242],"2,":[243],"5,":[244],"11":[246],"11,":[248],"22,":[249],"49":[251],"times,":[252],"respectively,":[253],"2":[256],"substrates).":[257],"Conclusion.":[258],"most":[260],"macrolides":[261],"ketolides,":[263],"found":[267],"be":[269],"noninhibitor":[271],"key":[274],"isoforms":[277],"even":[278,295],"at":[279],"significantly":[280],"concentrations.":[282],"TDI":[287],"noted":[292],"that":[294],"metabolites":[297],"do":[301],"have":[303],"cause":[306],"inhibition.":[308],"Cumulatively,":[309],"results":[311],"suggest":[312],"lower":[314],"clinical":[317],"(Nafithromycin).":[323],"Disclosures.":[324],"R.":[325,343],"Chavan,":[326],"Wockhardt":[327,336,345,356],"Ltd,:":[328],"Employee,":[329,338],"Research":[330,339,350,361],"support":[331,340,351,362],"Salary":[333,342,353,364],"V.":[334],"Zope,":[335],"Ltd:":[337,346,357],"Yeole,":[344],"Employee":[347,358],"Shareholder,":[349,360],"M.":[354],"Patel,":[355]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-11-30T00:00:00"}